Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: A double-blind placebo-controlled trial

Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: A double-blind placebo-controlled trial

The objective was to examine duloxetine 60–120mg/day treatment for relapse prevention in adults with generalized anxiety disorder (GAD). Adult patients (N=887; mean age=43.3 years; 61.0% female) with DSM-IV-TR-defined GAD diagnosis were treated with duloxetine for 26 weeks. Patients who completed op...

Full description

Bibliographic Details
Main Authors: Davidson, Jonathan R.T., Wittchen, Hans-Ulrich, Llorca, Pierre-Michel, Erickson, Janelle, Detke, Michael, Ball, Susan G., Russell, James M.
Other Authors: Technische Universität Dresden, Fakultät Mathematik und Naturwissenschaften
Format: Article
Language:English
Published: Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden 2013
Subjects:
Generalisierte Angststörung
Duloxetin
Rückfall-Verhinderung
Behandlung
Antidepressiva
Serotonin-Noradrenalin-Wiederaufnahmehemmer
Generalized anxiety disorder
Duloxetine
Relapse prevention
Treatment
Antidepressant
Serotonin and norepinephrine reuptake inhibitor
ddc:150
rvk:CU 3100
Online Access:http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-110320
http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-110320
http://www.qucosa.de/fileadmin/data/qucosa/documents/11032/991_PP.pdf

Internet

http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-110320
http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-110320
http://www.qucosa.de/fileadmin/data/qucosa/documents/11032/991_PP.pdf

Similar Items